Delivery Order SPE2DB25D3201-SPE2DB25FNSKL

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Advair HFA 230-21 mcg inhalers, with a ceiling value of $1,454.55 and a performance period ending on April 24, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a prescription medication. The contract has a ceiling value of $4,058.22 and a period of performance through May 14, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the pharmaceutical product Advair HFA 230-21 MCG Inhaler 12GM. The contract has a firm fixed price of $3,070.68 and a period of performance ending on May 16, 2025. The contract is not set aside for any specific business categories. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 45-21 MCG Inhaler 12GM. The contract has a ceiling value of $1,738.50 and is a firm fixed-price delivery order, with an ultimate completion date of April 8, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG inhalers, with a ceiling value of $5,549.74 and a period of performance through April 11, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of an Advair HFA 230-21 mcg inhaler with a total ceiling value of $1,749.95. The contract has a firm fixed price and an ultimate completion date of February 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Advair HFA 230-21 MCG Inhalers, with a firm fixed price ceiling value of $11,191.48 and a completion date of May 16, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 MCG Inhaler 12GM. The contract has a ceiling value of $12,996.79 and runs through February 16, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG Inhaler 12GM. The contract has a ceiling value of $4,650.78 and a completion date of June 7, 2024. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Advair HFA 115-21 MCG Inhaler, a prescription medication, with a ceiling value of $2,650.44 and a period of performance through May 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNSKL
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 230-21 MCG Inhaler 12GM. The contract has a ceiling value of $1,823.28 and a period of performance through April 16, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/17/25, 6:07 PM